Vimarsana
Biggest News Aggregation in the World

Baxter Sharesource News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Baxter Sharesource. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Baxter Sharesource Today - Breaking & Trending Today

Baxter To Spin-Off Vantive (Kidney Care Unit) In July 2024 - Vimarsana News

Baxter To Spin-Off Vantive (Kidney Care Unit) In July 2024

On February 8, 2024, Baxter International Inc. (NYSE: BAX, $39.64, Market Capitalization: $20.1 billion), a global medtech leader, reported steady 4Q23 results, with a...

Source: forbes.com
Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure - Vimarsana News

Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure

06.11.2023 - Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data indicating Baxter’s Sharesource remote patient management (RPM) digital platform, when used with an automated peritoneal ... Seite 1

DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter Technology - Vimarsana News

DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter Technology

DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter Technology Investment in Baxter system supports more informed clinical decision-making through connective technology News provided by Share this article Share this article DENVER, May 10, 2021 /PRNewswire/ -- DaVita Kidney Care today announced the expansion of its home kidney care program to include the HomeChoice Claria Automated Peritoneal Dialysis (APD) system enabled by Sharesource remote patient monitoring from Baxter International Inc., a global innovator in renal care. This new technology further enhances DaV...